« Back

Press Release

Technip publishes its « Document de Référence 2010 »

March 25, 2011

Technip’s “Document de Référence 2010” was filed with the French “Autorité des Marchés Financiers” (AMF) on March 24, 2011.

The document is available on the Company’s website: www.technip.com. Copies are also available at Technip’s registered office: 89 avenue de la Grande Armée 75116 Paris, France. The following documents are incorporated into the “Document de Référence 2010”:

  • 2010 Annual Financial Report,
  • Chairman’s Report on the operation of the Board of Directors and internal control procedures and corresponding Statutory Auditors’ Report in accordance with article L.225-235 of the French Commercial Code on the report prepared by the Chairman of the Board of Technip,
  • Statement of Statutory Auditors’ fees.

The English version of the Technip’s “Document de Reference 2010” will be available on our website on March 28, 2011.



Technip is a world leader in the fields of project management, engineering and construction for the oil & gas industry, offering a comprehensive portfolio of innovative solutions and technologies.

With 23,000 employees around the world, integrated capabilities and proven expertise in underwater infrastructures (Subsea), offshore facilities (Offshore) and large processing units and plants on land (Onshore), Technip is a key contributor to the development of sustainable solutions for the energy challenges of the 21st century.

Present in 48 countries, Technip has operating centers and industrial assets (manufacturing plants, spoolbases, construction yard) on five continents, and operates its own fleet of specialized vessels for pipeline installation and subsea construction.


Public Relations

Christophe Bélorgeot : Tel. +33 (0)1 47 78 39 92

Floriane Lassalle-Massip : Tel. + 33 (0)1 47 78 32 79 press@technip.com


Investor and Analyst Relations

Kimberly Stewart : Tel. + 33 (0)1 47 78 66 74 kstewart@technip.com


Group website



The Technip share is listed on Euronext Paris exchange and over the counter (OTC) in the USA.